Sage Therapeutics
SAGE
$11.90
Share price
-3.57%
Change (1 day)
-77.37%
Change (1 year)
Categories
Sage Therapeutics (SAGE) - Total assets
Total assets on the balance sheet as of March 2024 : $0.76 B
According to Sage Therapeutics 's latest financial reports the company's total assets are $0.76 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Sage Therapeutics - Total assets on balance sheet (from 2013 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.88 B | -34.96% |
| 2022-12-31 | $1.35 B | -25.69% |
| 2021-12-31 | $1.82 B | -15.47% |
| 2020-12-31 | $2.15 B | 99.16% |
| 2019-12-31 | $1.08 B | 13.8% |
| 2018-12-31 | $0.95 B | 79.78% |
| 2017-12-31 | $0.52 B | 31% |
| 2016-12-31 | $0.40 B | 114.02% |
| 2015-12-31 | $0.18 B | 45.77% |
| 2014-12-31 | $0.12 B | 1419.75% |
| 2013-12-31 | $8.53 M | 184.87% |
| 2012-12-31 | $2.99 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | $30.75 M | -95.99% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $0.39 B | -48.78% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $9.29 B | 1,111.40% | 🇮🇪 Ireland |
 Eagle Pharmaceuticals
EGRX | $0.40 B | -47.26% | 🇺🇸 USA |